Financial Performance - Revenues for Q1 2025 were 61.4million,adecreaseof30.187.8 million in Q1 2024[9] - Net Loss for Q1 2025 was (2.9)million,improvedby5.1 million from (8.1)millioninQ12024[9]−AdjustedEBITDAforQ12025was(2.3) million, down 6.5millionfrom4.3 million in Q1 2024[9] - Gross profit for Q1 2025 was 9.0million,downfrom14.8 million in Q1 2024, reflecting a gross margin decline[29] - Operating loss for Q1 2025 was 14.3million,comparedtoalossof3.6 million in Q1 2024[29] - Free Cash Flow for Q1 2025 was (49.1)million,comparedto0.4 million in Q1 2024[9] - Net cash used in operating activities for Q1 2025 was (45.1)million,anincreaseof47.8 million from 2.8millioninQ12024[9]−NetincomeforthethreemonthsendedMarch31,2025,wasalossof2,948,000, an improvement from a loss of 8,096,000forthesameperiodin2024[32]−AdjustedEBITDAforthethreemonthsendedMarch31,2025,was(2,268,000), compared to 4,281,000forthesameperiodin2024[36]−FreecashflowforthethreemonthsendedMarch31,2025,was(49,136,000), compared to 397,000forthesameperiodin2024[40]LiquidityandAssets−Totalliquidityreachedarecord89.2 million, consisting of 54.2millionincashandcashequivalentsand35.0 million in available borrowings[2][9] - Total current assets increased to 142.1millionasofMarch31,2025,upfrom125.9 million at the end of 2024[27] - Total liabilities decreased to 247.4millionasofMarch31,2025,downfrom344.5 million at the end of 2024[27] - Cash, cash equivalents, and restricted cash at the end of the period were 54,221,000,upfrom32,569,000 at the end of the same period in 2024[32] Contracts and Backlog - Book-to-Bill ratio increased significantly to 0.92 in Q1 2025, compared to 0.40 in Q1 2024[9] - Significant contracts awarded include a NASA contract for launching pharmaceutical investigations and a contract from Thales Alenia Space for the Lunar I-Hab module[1][2] - Total contracts awarded for the three months ended March 31, 2025, were 56,244,000,comparedto35,101,000 for the same period in 2024[43] - The contracted backlog as of March 31, 2025, was 291,219,000,aslightdecreasefrom296,652,000 as of December 31, 2024[48] - The company recognized 57,568,000inorganicrevenueduringthethreemonthsendedMarch31,2025[48]−Thecompany’sorganicbacklogattheendoftheperiodwas279,363,000, compared to 280,969,000atthebeginningoftheperiod[48]AcquisitionandRisks−ThecompanyannouncedtheacquisitionofEdgeAutonomy,receivingallregulatoryapprovalsforthetransaction[1]−Redwire′sAdjustedEBITDAandFreeCashFlowforecastsarenotprovidedduetouncertaintiessurroundingtheacquisitionofEdgeAutonomy[20]−ThecompanyisfacingrisksrelatedtotheacquisitionofEdgeAutonomy,includingpotentialdilutionofexistingshareholders[19]−EdgeAutonomy′srevenueissignificantlyimpactedbysalestocustomersinUkraine,whichhavebeendecliningduetoongoingconflicts[19]−Thecompanyincurred3,799,000 in transaction expenses related to acquisitions during the three months ended March 31, 2025[36]